Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s share price traded up 0.8% during mid-day trading on Thursday . The company traded as high as $5.36 and last traded at $5.36. 7,062 shares changed hands during mid-day trading, an increase of 73% from the average session volume of 4,089 shares. The stock had previously closed at $5.32.
Knight Therapeutics Stock Performance
The company’s 50-day moving average is $4.59 and its 200-day moving average is $4.40.
Knight Therapeutics Company Profile
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.
Featured Stories
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
